HRMY
Harmony Biosciences Holdings
41.20$
+1.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.3% | +4.4% | +1.3% | +8.1% | +7.7% | +5.6% | +5.0% | +9.0% | +5.2% | +0.0% | +8.0% | |
| – | -2.6% | +6.3% | -4.4% | +14.0% | +10.9% | +11.0% | +7.6% | +21.3% | +8.1% | -14.1% | +4.6% | |
| – | -4.0% | +6.8% | -4.7% | +22.1% | +16.9% | +7.9% | +11.7% | +18.5% | +16.3% | -21.7% | -6.7% | |
| – | -4.6% | +5.3% | -6.8% | +18.3% | +13.8% | +8.5% | +11.5% | +19.0% | +15.3% | -17.3% | +4.2% | |
| – | +10.2% | +7.5% | +4.3% | -2.0% | +1.9% | +27.6% | -12.3% | +8.2% | -3.8% | +11.8% | +2.6% | |
| – | +5.4% | +9.2% | -3.7% | +22.5% | +4.1% | -11.3% | -4.4% | +12.8% | -22.2% | -1.4% | +20.4% | |
| – | -4.2% | -4.3% | -4.5% | -4.8% | -5.0% | -5.3% | -5.6% | -5.9% | -6.3% | -6.7% | -7.1% | |
| – | +16.2% | -3.7% | -3.6% | +3.6% | +2.6% | -1.5% | 0.0% | +11.4% | +7.6% | -9.9% | +3.4% | |
| – | +45.7% | -5.8% | -5.0% | +10.0% | +8.6% | +0.0% | +2.9% | +24.0% | +12.9% | -13.8% | +7.7% | |
| – | -1.5% | +2.2% | 0.0% | -1.5% | +6.3% | +6.1% | +5.1% | +6.3% | +317.2% | -27.3% | -68.3% | |
| – | +171.1% | -14.6% | +49.8% | -53.6% | +30.5% | +27.0% | +62.1% | -6.9% | -32.8% | +61.6% | -24.2% | |
| – | -2.0% | -2.0% | -2.0% | -2.1% | -2.9% | -3.0% | -3.1% | -3.2% | -3.3% | -3.4% | -3.5% | |
| – | -3.0% | +10.4% | +4.5% | +10.8% | +10.4% | +9.3% | +7.3% | +8.0% | +4.2% | +4.6% | +9.8% | |
| – | – | – | – | – | – | +2,056.0% | +83.3% | +58.1% | +16.2% | +20.2% | +39.0% | |
| – | -3.0% | -2.1% | -0.1% | +1.0% | +0.2% | +0.5% | -0.2% | +0.5% | 0.0% | +0.1% | 0.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.